Sharps Technology, Inc. (STSS)
$
9.12
-0.18 (-1.97%)
Key metrics
Financial statements
Free cash flow per share
-9.8833
Market cap
9.3 Million
Price to sales ratio
43.5053
Debt to equity
0
Current ratio
4.1806
Income quality
10.7235
Average inventory
1.8 Million
ROE
-0.0872
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Sharps Technology Inc. is a medical device company dedicated to the research, design, development, manufacturing, distribution, and sale of safety syringe products in the United States. The company reported a net loss of -$9,296,202.00 indicating challenges in its operations, while its EBITDA is -$9,626,710.00 a key indicator of the company's operational profitability. Additionally, the company reported selling, general, and administrative expenses of $7,154,948.00 which reflects its operational overhead costs. Despite these challenges, Sharps Technology achieved a revenue of $0.00 indicating its niche market focus. The gross profit ratio is $0.00 reflecting the efficiency of the company's production and sales operations. Incorporated in 2017, this organization is based in Melville, New York, and offers the Sharps Provensa, an ultra-low waste space syringe aimed at the administration of various vaccines and injectable medications. The stock is affordable at $9.12 suitable for budget-conscious investors. However, it has a low average trading volume of $1,178,598.00 indicating lower market activity. With a market capitalization of $9,331,712.00 the company is classified as a small-cap player. It is a key player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Healthcare sector, driving innovation and growth. As Sharps Technology navigates its operational hurdles, it remains committed to serving its specialized market while striving for growth within its competitive industry landscape.
Is Sharps Technology, Inc. (STSS) a good investment?
Investing in Sharps Technology, Inc. (STSS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bearish outlook. Always conduct your own research before investing.
What is Sharps Technology, Inc. (STSS)'s stock forecast?
Analysts predict Sharps Technology, Inc. stock to fluctuate between $3.30 (low) and $1,735.80 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Sharps Technology, Inc.'s market capitalization?
As of 2025-09-12, Sharps Technology, Inc.'s market cap is $9,331,712, based on 1,023,214 outstanding shares.
How does Sharps Technology, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Sharps Technology, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Sharps Technology, Inc. (STSS) stock?
To buy Sharps Technology, Inc. (STSS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for STSS. Place an order (Market, Limit, etc.).
What is the best time to invest in Sharps Technology, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Sharps Technology, Inc. stock ever split?
Sharps Technology, Inc.'s last stock split was 1:300 on 2025-04-28.
How did Sharps Technology, Inc. perform in the last earnings report?
Revenue: $0 | EPS: -$2,220.05 | Growth: 781.92%.
Where can I find Sharps Technology, Inc.'s investor relations reports?
Visit https://sharpstechnology.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Sharps Technology, Inc.?
You can explore historical data from here
What is the all-time high and low for Sharps Technology, Inc. stock?
All-time high: $79.64 (2022-04-19) | All-time low: $0.01 (2025-04-09).
What are the key trends affecting Sharps Technology, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
Transaction could raise up to $1 billion in aggregate gross proceeds if all of the warrants are exercised, which would make Sharps Technology one of the largest Solana treasury companies Subscribers included preeminent financial institutions and digital asset market leaders such as ParaFi, Pantera, Monarq, FalconX, Phoenix Digital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, Arrington Capital, Hypersphere, Quantstamp, FinTech Collective, CoinList Alpha, Primitive Ventures, Avenir Group, Luca Netz, Cube, and Saba Capital, among others NEW YORK , Aug. 28, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced the closing of its previously announced private placement offering of common stock and stapled warrants to purchase shares of common stock at a purchase price of $6.50 per unit. The transaction generated gross proceeds of over $400 million, and an additional $600 million could be raised if all of the warrants are exercised, which could increase total proceeds to $1 billion.
invezz.com
Sharps Technology stock (NASDAQ: STSS) surged 56% on Wednesday, following the company's announcement of a $400 million private placement to create the largest Solana blockchain-backed digital asset treasury in the corporate sector.
prnewswire.com
Investors include leading financial institutions and digital asset market leaders such as ParaFi, Pantera, Monarq, FalconX, Phoenix Capital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, CoinFund, Arrington Capital, Quantstamp, CoinList Alpha, Primitive Ventures, Avenir, Hypersphere, and more NEW YORK , Aug. 25, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced the pricing of a private placement offering to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Solana is the fastest and most used public blockchain in the world, processing more transactions and generating more onchain fee revenue than all other blockchains combined.
marketwatch.com
Shares of Sharps Technology jumped after the company said it has initiated a second shipment from its first commercial order of SoloGard syringes.
globenewswire.com
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
globenewswire.com
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here.
benzinga.com
Sharps Technology, Inc. STSS stock is trading higher on Wednesday.
globenewswire.com
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET. Presentation Details: Presenter: Robert Hayes, CEO Date: May 22, 2025 Time: 1:00 p.m.
See all news
